Enhancing the QUAlity and Transparency Of health Research
Search for reporting guidelines
Use your browser's Back button to return to your search results
Heterogeneity in the Identification of Potential Drug -Drug Interactions in the Intensive Care Unit: A Systematic Review, Critical Appraisal, and Reporting Recommendations
| Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Reporting of potential drug-drug interaction (pDDI) frequency studies in the intensive care unit (ICU). |
| Full bibliographic reference | Bakker T, Dongelmans DA, Nabovati E, Eslami S, de Keizer NF, Abu-Hanna A, Klopotowska JE. Heterogeneity in the Identification of Potential Drug-Drug Interactions in the Intensive Care Unit: A Systematic Review, Critical Appraisal, and Reporting Recommendations. J Clin Pharmacol. 2021. |
| Language | English |
| PubMed ID | 34957573 |
| Relevant URLs (full-text if available) |
Read the full-text of this reporting guideline. |
| Study design | Observational studies |
| Applies to the whole report or to individual sections of the report? | Procedure/Method, Study characteristics (participants etc.) |
| Record last updated on | March 10, 2022 |